Clinical features of Bacteroides bacteremia and their association with colorectal carcinoma

Infection

Volumn 40, Issue 1, 2012, Pages 63-67

  Yoshino, Y ^a   Kitazawa, T ^b   Ikeda, M ^a   Tatsuno, K ^a   Yanagimoto, S ^a   Okugawa, S ^a   Ota, Y ^b   Yotsuyanagi, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Bacteremia; Bacteroides spp.; Clinical features; Colorectal carcinoma

Indexed keywords

AMPICILLIN; CARBAPENEM; CEFOZOPRAN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; PIPERACILLIN;

ABSCESS DRAINAGE; ARTERIOVENOUS SHUNT; BACTEREMIA; BACTEROIDES; BACTEROIDES EGGERTHII; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS; CANCER SCREENING; CANCER SURGERY; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CARCINOMA; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HEMORRHOIDECTOMY; HUMAN; JAPAN; LIVER TRANSPLANTATION; MALE; MORTALITY; PERITONEUM LAVAGE; PRIMARY INFECTION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SUTURE; TEACHING HOSPITAL;

AGED; BACTEREMIA; BACTEROIDES; BACTEROIDES INFECTIONS; CARCINOMA; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOKYO;

EID: 84857720940     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0159-8     Document Type: Review

References (20)

1. I Brook 2010 The role of anaerobic bacteria in bacteremia Anaerobe 16 183 189 20025984 10.1016/j.anaerobe.2009.12.001 1:CAS:528:DC%2BC3cXmvVWjsb4%3D
2. HM Wexler 2007 Bacteroides: the good, the bad, and the nitty-gritty Clin Microbiol Rev 20 593 621 17934076 10.1128/CMR.00008-07 1:CAS:528: DC%2BD2sXhtleltrfJ (Pubitemid 47623770)
3. SM Finegold WL George ME Mulligan 1985 Anaerobic infections. Part I Dis Mon 31 1 77
4. LJ Wheat SD Allen M Henry CB Kernek JA Siders T Kuebler N Fineberg J Norton 1986 Diabetic foot infections. Bacteriologic analysis Arch Intern Med 146 1935 1940 3767539 10.1001/archinte.1986.00360220079017 1:STN:280: DyaL2s%2FisVyqtQ%3D%3D (Pubitemid 16006683)
5. WR Wilson WJ Martin CJ Wilkowske JA Washington 1972 2nd: anaerobic bacteremia Mayo Clin Proc 47 639 646 5073944 1:STN:280:DyaE3s%2FhtVaquw%3D%3D
6. PA James KM Al-Shafi 2000 Clinical value of anaerobic blood culture: a retrospective analysis of positive patient episodes J Clin Pathol 53 231 233 10823145 10.1136/jcp.53.3.231 1:STN:280:DC%2BD3c3ot1GmsQ%3D%3D (Pubitemid 30163609)
7. JH Salonen E Eerola O Meurman 1998 Clinical significance and outcome of anaerobic bacteremia Clin Infect Dis 26 1413 1417 9636872 10.1086/516355 1:STN:280:DyaK1czgtVGjsw%3D%3D (Pubitemid 28270174)
8. B Lassmann DR Gustafson CM Wood JE Rosenblatt 2007 Reemergence of anaerobic bacteremia Clin Infect Dis 44 895 900 17342637 10.1086/512197 (Pubitemid 46452050)
9. NU Toprak A Yagci BM Gulluoglu ML Akin P Demirkalem T Celenk G Soyletir 2006 A possible role of B. fragilis enterotoxin in the aetiology of colorectal cancer Clin Microbiol Infect 12 782 786 16842574 1:CAS:528:DC%2BD28XosFamu7k%3D (Pubitemid 43983804)
10. S Wu KJ Rhee E Albesiano S Rabizadeh X Wu HR Yen DL Huso FL Brancati E Wick F McAllister F Housseau DM Pardoll CL Sears 2009 A human colonic commensal promotes colon tumorigenesis via activation of t helper type 17 t cell responses Nat Med 15 1016 1022 19701202 10.1038/nm.2015 1:CAS:528:DC%2BD1MXhtVersbvJ
11. RS Klein RA Recco MT Catalano SC Edberg JI Casey NH Steigbigel 1977 Association of Streptococcus bovis with carcinoma of the colon N Engl J Med 297 800 802 408687 10.1056/NEJM197710132971503 1:STN:280:DyaE2s3lsV2muw%3D%3D (Pubitemid 8194801)
12. Clinical Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standards. M11-A7. 7th ed. Wayne, PA: Clinical Laboratory Standards Institute; 2007.
13. JL Vincent R Moreno J Takala S Willatts A De Mendonca H Bruining CK Reinhart PM Suter LG Thijs 1996 The sofa (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710 8844239 10.1007/BF01709751 1:STN:280:DyaK2s%2FgtFantQ%3D%3D
14. MC Redondo MD Arbo J Grindlinger DR Snydman 1995 Attributable mortality of bacteremia associated with the B. fragilis group Clin Infect Dis 20 1492 1496 7548498 10.1093/clinids/20.6.1492 1:STN:280:DyaK28%2FjsV2nsg%3D%3D
15. CW Cheng HS Lin JJ Ye CC Yang PC Chiang TS Wu MH Lee 2009 Clinical significance of and outcomes for B. fragilis bacteremia J Microbiol Immunol Infect 42 243 250 19812858
16. MH Nguyen VL Yu AJ Morris L McDermott MW Wagener L Harrell DR Snydman 2000 Antimicrobial resistance and clinical outcome of bacteroides bacteremia: findings of a multicenter prospective observational trial Clin Infect Dis 30 870 876 10852736 10.1086/313805 1:STN:280:DC%2BD3cvisVOguw%3D%3D (Pubitemid 32250323)
17. DR Snydman NV Jacobus LA McDermott R Ruthazer Y Golan EJ Goldstein SM Finegold LJ Harrell DW Hecht SG Jenkins C Pierson R Venezia V Yu J Rihs SL Gorbach 2007 National survey on the susceptibility of B. fragilis group: report and analysis of trends in the United States from 1997 to 2004 Antimicrob Agents Chemother 51 1649 1655 17283189 10.1128/AAC.01435-06 1:CAS:528: DC%2BD2sXlt1yjs7w%3D (Pubitemid 46744140)
18. DR Snydman NV Jacobus LA McDermott 2008 In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the B. fragilis group Antimicrob Agents Chemother 52 4492 4496 18838581 10.1128/AAC.00696-08 1:CAS:528:DC%2BD1cXhsV2mu7%2FF
19. AP Panwalker 1988 Unusual infections associated with colorectal cancer Rev Infect Dis 10 347 364 3287564 10.1093/clinids/10.2.347 1:STN:280: DyaL1c3jsFGqug%3D%3D
20. E Sanchez F Casafont A Guerra I de Benito F Pons-Romero 2005 Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis Rev Esp Enferm Dig 97 805 814 16438624 1:STN:280:DC%2BD28%2FpsFOntg%3D%3D (Pubitemid 44400602)